FDA Approves First Drug For Treatment Of Thyroid Eye Disease

The drug is administered via intravenous therapy (IV), with eight infusions over a six month period. Each infusion can take between an hour to an hour and a half.

from Forbes Real Time https://ift.tt/2O0mVey